4//SEC Filing
Brann Mark R 4
Accession 0001181431-06-019250
CIK 0001070494other
Filed
Mar 20, 7:00 PM ET
Accepted
Mar 21, 9:36 PM ET
Size
11.7 KB
Accession
0001181431-06-019250
Insider Transaction Report
Form 4
Brann Mark R
DirectorPresident & CSO
Transactions
- Sale
Common Stock
2006-03-20$15.85/sh−5,000$79,250→ 342,756 total(indirect: By Trust) - Sale
Common Stock
2006-03-17$17.41/sh−12,500$217,625→ 363,756 total(indirect: By Trust) - Sale
Common Stock
2006-03-20$15.61/sh−16,000$249,760→ 347,756 total(indirect: By Trust) - Sale
Common Stock
2006-03-17$17.30/sh−1,500$25,950→ 376,256 total(indirect: By Trust)
Holdings
- 52,593
Common Stock
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected pursuant to an existing sales plan established under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
Documents
Issuer
ACADIA PHARMACEUTICALS INC
CIK 0001070494
Entity typeother
Related Parties
1- filerCIK 0001291968
Filing Metadata
- Form type
- 4
- Filed
- Mar 20, 7:00 PM ET
- Accepted
- Mar 21, 9:36 PM ET
- Size
- 11.7 KB